Rheumatoid arthritis (RA)
S. Louis Bridges, Jr, MD, PhD
Hospital for Special Surgery
Gerd Burmester, MD
Charité – University Medicine Berlin
This session will review the development of biologics from the first antibody treatment against diphtheria. Faculty will take participants through the development of monoclonal antibodies, present-day indications of biologics and future developments in this area, including biosimilars.